News

In an opinion piece published in The Hill, distinguished professor of health policy and management Dr. Jonathan Fielding, discusses health risks that ensue from noise exposure.

In an opinion piece published in The Hill, Dr. Jonathan Fielding, distinguished professor of health policy and management at the UCLA Fielding School of Public Health, calls attention to the measles outbreak as a public-health emergency.

Dr. Jonathan Fielding, distinguished professor of health policy and management, co-authored an opinion piece for The Washington Post about the steps the U.S. federal government should take, according to the authors: "Federal policymakers have a responsibility to protect those children who have been put at risk whenever a parent claims the 'right' to refuse vaccination."

In a recent opinion piece published in The Hill, Dr. Jonathan Fielding, distinguished professor of health policy and management at the UCLA Fielding School of Public Health, states that "an addiction epidemic caused by nicotine products targeting our kids is irrefutable."

In a recent opinion piece published in The Hill, Dr. Jonathan Fielding, distinguished professor of health policy and management at the UCLA Fielding School of Public Health, discusses causes of foodborne illnesses, and the need to eradicate this public health threat.

The six-year-long study about endocrine treatment was co-authored by FSPH professors Dr. Patricia Ganz and Catherine Crespi.

UCLA Fielding School of Public Health faculty members Ronald Hays, Steve Horvath, Michael Jerrett, André Nel, Beate Ritz and Marc Suchard have been named to Clarivate Analytics' annual list of highly cited researchers.

In a recent opinion piece published in The Hill, Dr. Jonathan Fielding, distinguished professor of health policy and management at the UCLA Fielding School of Public Health, points out the lack of evidence behind health claims associated with marijuana.

The study, led by Dr. Patricia Ganz, director of prevention and control research at the UCLA Jonsson Comprehensive Cancer Center and a distinguished professor at the UCLA Fielding School of Public Health, followed women with early-stage breast cancer for up to six years after they had completed their primary cancer treatments.